drugset / Trial / NCT00991458
Study of Cyclosporine in Post-LASIK Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.
Timeline
- Start
- 2009-10
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.005 % | Other |
| Subject | Cyclosporine | Peptide | 0.01 % | Other |
Indications
No indication recorded.